US equities
|
MU
$1,088.00
▲+4.06%
NVDA
$237.47
▼-0.74%
SNDK
$1,692.42
▲+1.92%
SPCX
$167.60
▼-2.51%
AMD
$645.86
▼-0.55%
AAPL
$336.67
▲+0.91%
TSLA
$377.81
▼-0.75%
META
$721.31
▼-2.38%
MU
$1,088.00
▲+4.06%
NVDA
$237.47
▼-0.74%
SNDK
$1,692.42
▲+1.92%
SPCX
$167.60
▼-2.51%
AMD
$645.86
▼-0.55%
AAPL
$336.67
▲+0.91%
TSLA
$377.81
▼-0.75%
META
$721.31
▼-2.38%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Gemina Laboratories Ltd
(CSE:
GLAB
)
0.0300
UNCHANGED
Last Price
Updated: 9:30 AM EDT, Mar 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gemina Laboratories Ltd
< Previous
1
2
Next >
Gemina Announces Filing of Prospectus Supplement
June 24, 2022
VANCOUVER, BC / ACCESSWIRE / June 24, 2022 / Gemina Laboratories Ltd. (the "Company" or "Gemina") (CSE:GLAB)(FRA:8I7) is pleased to announce that the Company has entered into an agency agreement dated...
From
Gemina Laboratories Ltd.
Via
AccessWire
Gemina Announces Proposed Financing Up to $5 Million
June 21, 2022
VANCOUVER, BC / ACCESSWIRE / June 21, 2022 / Gemina Laboratories Ltd. (the "Company" or "Gemina") (CSE:GLAB) (FRA:8I7) is pleased to announce that the Company has engaged Leede Jones Gable Inc., as...
From
Gemina Laboratories Ltd.
Via
AccessWire
Gemina Labs Appoints Point-of-Care Diagnostic Executive Brian Firth as Advisor
June 08, 2022
VANCOUVER, BC / ACCESSWIRE / June 8, 2022 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to announce the appointment of Brian Firth as an adviser to the Company.
From
Gemina Laboratories Ltd.
Via
AccessWire
Gemina Labs Announces CE Mark for its First Product - The Best in Class Legio-X COVID Rapid Antigen Test
May 17, 2022
- Less than two weeks after announcing the highly successful completion of human trials, Gemina has secured a European Union ("EU") CE Mark, which accelerates commercialization of the breakthrough...
From
Gemina Laboratories Ltd.
Via
AccessWire
Gemina Labs Completes Successful Human Clinical Performance Evaluation on its Legio X COVID-19 Rapid Antigen Test
May 05, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From
Gemina Laboratories Ltd.
Via
AccessWire
Gemina Labs Nears Completion of Phase 2 Human Patient Testing for Initial Diagnostic Test
April 28, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From
Gemina Laboratories Ltd.
Via
AccessWire
Gemina Labs Provides Technical Development Update for Initial Diagnostic Test and Reports Filing of New IP
March 31, 2022
VANCOUVER, BC / ACCESSWIRE / March 31, 2022 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to provide recent development updates for its initial diagnostic test...
From
Gemina Laboratories Ltd.
Via
AccessWire
Gemina Labs Establishes UK Subsidiary And Appoints David Browning As Head Of Productization
February 23, 2022
VANCOUVER, BC / ACCESSWIRE / February 23, 2022 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to announce the formation of a wholly owned UK Subsidiary, Gemina...
From
Gemina Laboratories Ltd.
Via
AccessWire
Gemina Labs Strategic Update: From Product to Platform, Gemina Provides a Technology Roadmap
February 15, 2022
VANCOUVER, BC / ACCESSWIRE / February 15, 2022 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to provide the following strategic overview and share an outlook for...
From
Gemina Laboratories Ltd.
Via
AccessWire
Gemina Labs Announces Completion of Significant Development Step for its SARS-CoV-2 Rapid Test
February 03, 2022
VANCOUVER, BC / ACCESSWIRE / February 3, 2022 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to provide an update on its current activities related to the...
From
Gemina Laboratories Ltd.
Via
AccessWire
Gemina Labs Announces Appointment Of Senior Scientific Adviser
November 18, 2021
VANCOUVER, BC / ACCESSWIRE / November 18, 2021 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to announce the appointment of Professor Michael Catt as Senior...
From
Gemina Laboratories Ltd.
Via
AccessWire
Gemina Labs Announces Closing of Oversubscribed Private Placement
October 25, 2021
VANCOUVER, BC / ACCESSWIRE / October 25, 2021 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to announce the closing of its previously announced CAD$2,000,000...
From
Gemina Laboratories Ltd.
Via
AccessWire
Gemina Labs Announces Private Placement
October 20, 2021
VANCOUVER, BC / ACCESSWIRE / October 20, 2021 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to announce a non-brokered private placement offering (the...
From
Gemina Laboratories Ltd.
Via
AccessWire
Gemina Labs Receives Positive Initial Manufacturing Results for SARS-CoV-2 Diagnostic Test
September 20, 2021
VANCOUVER, BC / ACCESSWIRE / September 20, 2021 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to provide an update on its current activities related to the...
From
Gemina Laboratories Ltd.
Via
AccessWire
Gemina Labs Provides Research and Development and Corporate Update
September 13, 2021
VANCOUVER, BC / ACCESSWIRE / September 13, 2021 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to provide an update on its research and development ("R&D")...
From
Gemina Laboratories Ltd.
Via
AccessWire
Gemina Labs Announces Research and Development Appointments
August 30, 2021
VANCOUVER, BC / ACCESSWIRE / August 30, 2021 / Gemina Laboratories Ltd. (CSE:GLAB) (the "Company" or "Gemina") is pleased to announce several key hires within our Research and Development team....
From
Gemina Laboratories Ltd.
Via
AccessWire
Gemina Labs Announces Listing on the Canadian Securities Exchange
August 10, 2021
VANCOUVER, BC / ACCESSWIRE / August 10, 2021 / Gemina Laboratories Ltd. (CSE:GLAB) (the "Company" or "Gemina") is pleased to announce that the common shares of the Company have begun trading on the...
From
Gemina Laboratories Ltd.
Via
AccessWire
< Previous
1
2
Next >
